Bicocca Open Archive

Logo unimib boa
BIONDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 78.418
AS - Asia 38.731
EU - Europa 31.276
SA - Sud America 5.615
Continente sconosciuto - Info sul continente non disponibili 3.098
AF - Africa 874
OC - Oceania 65
Totale 158.077
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 74.399
SG - Singapore 13.372
IT - Italia 9.657
CN - Cina 7.635
VN - Vietnam 5.844
HK - Hong Kong 5.489
RU - Federazione Russa 4.335
BR - Brasile 4.195
DE - Germania 3.331
CA - Canada 3.234
SE - Svezia 3.010
IE - Irlanda 2.745
UA - Ucraina 1.799
GB - Regno Unito 1.596
FR - Francia 1.397
BD - Bangladesh 1.232
IN - India 1.097
FI - Finlandia 872
ID - Indonesia 584
TR - Turchia 548
KR - Corea 544
AR - Argentina 484
NL - Olanda 451
AT - Austria 445
IQ - Iraq 377
MX - Messico 340
ES - Italia 317
JP - Giappone 309
ZA - Sudafrica 292
PK - Pakistan 285
PL - Polonia 269
SA - Arabia Saudita 230
CO - Colombia 209
EC - Ecuador 209
PH - Filippine 209
DK - Danimarca 204
VE - Venezuela 168
BE - Belgio 166
CH - Svizzera 149
UZ - Uzbekistan 117
CL - Cile 104
JM - Giamaica 97
EG - Egitto 86
AE - Emirati Arabi Uniti 84
MA - Marocco 84
JO - Giordania 78
KE - Kenya 78
MY - Malesia 78
PY - Paraguay 77
CR - Costa Rica 75
LT - Lituania 71
IR - Iran 69
PE - Perù 68
CZ - Repubblica Ceca 65
TN - Tunisia 65
ET - Etiopia 60
RO - Romania 59
UY - Uruguay 55
KZ - Kazakistan 53
TH - Thailandia 53
AU - Australia 52
NP - Nepal 51
GR - Grecia 49
IL - Israele 49
AZ - Azerbaigian 47
BG - Bulgaria 44
DZ - Algeria 42
OM - Oman 39
EU - Europa 38
TW - Taiwan 38
AL - Albania 36
HN - Honduras 36
NI - Nicaragua 35
LB - Libano 34
GT - Guatemala 33
BO - Bolivia 32
DO - Repubblica Dominicana 31
PT - Portogallo 31
TT - Trinidad e Tobago 31
PS - Palestinian Territory 30
PA - Panama 29
EE - Estonia 26
SN - Senegal 26
NG - Nigeria 25
NO - Norvegia 25
KG - Kirghizistan 24
AO - Angola 20
HR - Croazia 19
LV - Lettonia 19
RS - Serbia 18
BH - Bahrain 17
SV - El Salvador 16
SY - Repubblica araba siriana 16
AM - Armenia 15
BY - Bielorussia 14
HU - Ungheria 13
PR - Porto Rico 13
LY - Libia 12
XK - ???statistics.table.value.countryCode.XK??? 12
CI - Costa d'Avorio 11
Totale 154.752
Salva come PNG Salva come JPEG
Città #
Ann Arbor 8.965
Singapore 7.672
Ashburn 7.433
Hong Kong 5.353
Woodbridge 4.523
San Jose 4.455
Fairfield 4.227
Houston 3.621
Milan 2.807
Chandler 2.776
Dublin 2.642
Wilmington 2.452
Toronto 2.257
Frankfurt am Main 2.086
Jacksonville 1.878
Seattle 1.789
Ho Chi Minh City 1.750
New York 1.741
Santa Clara 1.519
Cambridge 1.461
Hanoi 1.429
Los Angeles 1.313
Dearborn 1.271
Chicago 1.214
Beijing 1.204
Council Bluffs 1.161
Princeton 1.019
Dallas 1.003
Hefei 947
The Dalles 849
Rome 675
Lauterbourg 546
Nanjing 529
Seoul 492
Lawrence 474
Altamura 460
Shanghai 460
Moscow 458
Buffalo 455
São Paulo 409
Boardman 401
Jakarta 395
Helsinki 354
Vienna 329
Lachine 309
San Diego 301
Munich 279
Phoenix 260
London 258
Orem 247
Tokyo 222
Brooklyn 218
Guangzhou 218
Columbus 211
Montreal 210
Denver 206
Atlanta 203
Warsaw 203
Dong Ket 200
Nuremberg 193
Haiphong 173
Lissone 173
Da Nang 171
Andover 169
Turin 164
Baghdad 155
Nanchang 155
Chennai 154
Rio de Janeiro 153
Brussels 152
Changsha 147
Johannesburg 140
Bologna 136
Shenyang 133
Stockholm 133
Tianjin 129
Hebei 128
Salt Lake City 127
Naples 126
Figino 121
Monza 121
Brasília 109
Poplar 109
Tashkent 108
Jinan 104
Turku 104
Dhaka 101
San Francisco 101
Ottawa 100
Philadelphia 100
Zurich 100
Boston 99
Biên Hòa 98
Mexico City 96
Mumbai 96
Manchester 95
Amsterdam 94
Florence 93
Hangzhou 93
Tampa 92
Totale 97.944
Salva come PNG Salva come JPEG
Nome #
Four Additional Doses of PEG-L-Asparaginase during the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study 572
miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation 569
BEYOND THE TUMOUR: CHILDHOOD CANCER PREDISPOSING SYNDROMES [Guardare oltre il tumore: le cancer-predisposingsyndrome in età pediatrica] 552
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 535
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels 534
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development 532
Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing 526
Intraperitoneal adoptive transfer of mesenchymal stem cells enhances recovery from acid aspiration acute lung injury in mice 524
Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action 516
Thyroid Function Tests in Children and Adolescents with Trisomy 21: Definition of Syndrome-Specific Reference Ranges 512
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 510
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 506
Mesenchymal stromal cell-secreted chemerin is a novel immunomodulatory molecule driving the migration of ChemR23-expressing cells 502
Studio preliminare sul profilo emotivo di un campione di bambini guariti da leucemia linfoblastica acuta 491
Hepatic granulomatous lesions caused by systemic bartonella vinsonii subsp. arupensis infection in a child 490
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 489
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 488
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort 488
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients 485
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry 482
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 477
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 477
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 472
NIPBL: a new player in myeloid cells differentiation 466
Acute myeloid leukaemia niche regulates response to L-asparaginase 466
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 465
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 455
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 444
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation 443
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 443
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 441
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 439
Crescere dopo il tumore: Le emozioni dei bambini guariti da leucemia linfoblastica acuta a confronto con quelle di altre popolazioni 434
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection 433
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 432
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 432
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 431
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis 428
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 426
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 424
Mapping the human genetic architecture of COVID-19 424
A second update on mapping the human genetic architecture of COVID-19 422
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 411
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 409
Healthcare costs and resources utilization in children with difficult-to-control asthma treated with biologic therapies: A population-based cohort study 407
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 405
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 405
A new case report of severe mucopolysaccharidosis type VII: Diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy 11 Medical and Health Sciences 1114 Paediatrics and Reproductive Medicine 402
Phenotypical and Functional Characterization of Mesenchymal Stem Cells Derived From Patients Affected by Schwachman-Diamond Syndrome 400
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 400
Moral distress in nurses in oncology and haematology units 399
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation 398
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells 398
From Adjustment to Thriving: Exploring Well-Being in Young Adult Survivors of Childhood Cancer and Their Siblings 388
A novel EP300 mutation associated with Rubinstein-Taybi syndrome type 2 presenting as combined immunodeficiency 387
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 386
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA 386
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice 384
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 384
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection 381
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 381
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 380
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 379
Mesenchymal stromal cell-derived PTX3 promotes wound healing via fibrin remodeling 377
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy 373
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 372
Globalization of pediatric research: Pharmacological RCTs in Latin America 369
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 368
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 368
Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR 366
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 366
An immune-based biomarker signature is associated with mortality in COVID-19 patients 365
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 363
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo 362
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 361
Prevalence of Immunological Defects in a Cohort of 97 Rubinstein–Taybi Syndrome Patients 361
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 360
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 358
Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals 357
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells 355
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo 355
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 354
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 353
Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model 353
Location First: Targeting Acute Myeloid Leukemia Within Its Niche 352
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 351
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 350
Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse 348
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 346
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 345
Characterization of Plated Lysate Cultured Mesenchymal Stromal Cells and Their Potential Use in Tissue-Engineered Osteogenic Devices for the Treatment of Bone Defects 344
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 343
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations 339
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 336
CD34(+) stem cell recovery after positive selection of "overloaded" immunomagnetic columns 335
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 334
Eight-year national multicenter experience on the use of glucarpidase as effective rescue therapy for delayed methotrexate elimination after high-dose methotrexate cycles administered in children with hemato-oncological diseases 332
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 332
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 330
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 329
Totale 41.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 503.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 503.523
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.181 0 0 0 528 429 516 350 389 572 540 597 1.260
2022/202311.423 1.435 3.400 833 1.009 707 1.700 194 679 747 95 409 215
2023/20248.937 308 289 438 478 1.135 2.267 1.639 318 754 190 282 839
2024/202522.128 1.148 2.327 1.266 1.021 1.853 899 1.486 801 2.267 3.113 1.987 3.960
2025/202656.977 6.892 3.802 3.929 6.006 6.385 2.909 7.539 2.540 4.095 4.621 3.876 4.383
2026/202711.518 2.038 2.569 5.788 1.123 0 0 0 0 0 0 0 0
Totale 158.077